FDA will evaluate Pfizer's request to allow Covid-19 vaccine for children ages 12-15 'as quickly as possible,' acting commissioner says

The Food and Drug Administration will evaluate "as quickly as possible" Pfizer's request to expand the emergency use authorization of the drug maker's Covid-19 vaccine to include people ages 12-15 in the United States, FDA Acting Commissioner Janet Woodcock said.

Click Here to read the entire article...